1 April 2023 false Taxfiler 2024.6 06890222business:PrivateLimitedCompanyLtd2023-04-012024-03-31 068902222023-03-31 068902222023-04-012024-03-31 06890222business:AuditExempt-NoAccountantsReport2023-04-012024-03-31 06890222business:FilletedAccounts2023-04-012024-03-31 068902222024-03-31 06890222business:Director12023-04-012024-03-31 06890222business:RegisteredOffice2023-04-012024-03-31 068902222023-03-31 06890222core:WithinOneYear2024-03-31 06890222core:WithinOneYear2023-03-31 06890222core:AfterOneYear2024-03-31 06890222core:AfterOneYear2023-03-31 06890222core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 06890222core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 06890222core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-03-31 06890222core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-03-31 06890222core:PreviouslyStatedAmount2024-03-31 06890222core:PreviouslyStatedAmount2023-03-31 06890222business:SmallEntities2023-04-012024-03-31 06890222countries:EnglandWales2023-04-012024-03-31 06890222core:PlantMachinery2023-04-012024-03-31 06890222core:PlantMachinery2023-03-31 06890222core:PlantMachinery2024-03-31 06890222business:OrdinaryShareClass12023-04-012024-03-31 06890222business:OrdinaryShareClass12022-04-012023-03-31 068902222022-04-012023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 06890222 (England and Wales)
Biovita Medical Limited Unaudited accounts for the year ended 31 March 2024
Biovita Medical Limited Unaudited accounts Contents
Page
- 2 -
Biovita Medical Limited Company Information for the year ended 31 March 2024
Director
James Hewitt
Company Number
06890222 (England and Wales)
Registered Office
Admirals Offices Main Gate Road The Historic Dockyard Chatham Kent ME4 4TZ England
- 3 -
Biovita Medical Limited Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Debtors
100 
- 
Cash at bank and in hand
1,478,623 
2,915,910 
1,478,723 
2,915,910 
Creditors: amounts falling due within one year
- 
(101)
Net current assets
1,478,723 
2,915,809 
Total assets less current liabilities
1,478,723 
2,915,809 
Creditors: amounts falling due after more than one year
(1,369,637)
(2,806,117)
Net assets
109,086 
109,692 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
109,085 
109,691 
Shareholders' funds
109,086 
109,692 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 October 2024 and were signed on its behalf by
James Hewitt Director Company Registration No. 06890222
- 4 -
Biovita Medical Limited Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
Biovita Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 06890222. The registered office is Admirals Offices, Main Gate Road, The Historic Dockyard, Chatham, Kent, ME4 4TZ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover from the sale of goods is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Such turnover is recognised when goods have been delivered to customers and the risks and rewards of ownership have transferred to them. Turnover also includes charges for services provided as an agent where there is no share in the profits of international business that is supported and title in the goods and all risks rests with a principal. Such services are provided from the UK in return for fees and commissions
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
33% straight line
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
- 5 -
Biovita Medical Limited Notes to the Accounts for the year ended 31 March 2024
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 April 2023
19,482 
At 31 March 2024
19,482 
Depreciation
At 1 April 2023
19,482 
At 31 March 2024
19,482 
Net book value
At 31 March 2024
- 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due after more than one year
Trade debtors
100 
- 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
- 
101 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Other creditors
1,369,637 
2,806,117 
8
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
9
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -